Intrastriatal injection of a muscarinic receptor agonist and antagonist regulates striatal neuropeptide mRNA expression in normal and amphetamine-treated rats

Brain Research

Volumn 748, Issue 1-2, 1997, Pages 62-70

  Wang, John Q ^a   McGinty, Jacqueline F ^a  

^a EAST CAROLINA UNIVERSITY   (United States)

Author keywords

accumbens; behavior; caudoputamen; dynorphin; enkephalin; oxotremorine; scopolamine; substance P

Indexed keywords

AMPHETAMINE; ENKEPHALIN; MESSENGER RNA; MUSCARINIC AGENT; MUSCARINIC RECEPTOR BLOCKING AGENT; OXOTREMORINE; SCOPOLAMINE; SUBSTANCE P;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BEHAVIOR; CONTROLLED STUDY; CORPUS STRIATUM; GENE EXPRESSION; IN SITU HYBRIDIZATION; INTRACEREBRAL DRUG ADMINISTRATION; MALE; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; RAT;

AMPHETAMINE; ANIMALS; BEHAVIOR, ANIMAL; CORPUS STRIATUM; DYNORPHINS; ENKEPHALINS; INJECTIONS; MALE; MUSCARINIC AGONISTS; MUSCARINIC ANTAGONISTS; NEUROPEPTIDES; OXOTREMORINE; PROTEIN PRECURSORS; RATS; RATS, WISTAR; REFERENCE VALUES; RNA, MESSENGER; SCOPOLAMINE; SUBSTANCE P;

EID: 0031052994     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(96)01244-9     Document Type: Article

References (43)

1. 2 and substance P (neurokinin-1) receptor messenger RNAs by a subpopulation of cholinergic neurons in the rat striatum, Neuroscience, 53 (1993) 417-424.
2. Bernard, V., Dumartin, B., Lamy, E. and Bloch, B., Fos immuno-reactivity after stimulation or inhibition of muscarinic receptors indicates anatomical specificity for cholinergic control of striatal efferent neurons and cortical neurons in the rat, Eur. J. Neurosci., 5 (1993) 1218-1225.
3. Bernard, V., Normand, E. and Bloch, B., Phenotypical characterization of the rat striatal neurons expressing muscarinic receptor genes, J. Neurosci., 12 (1992) 3591-3600.
4. Bhat, R.V. and Baraban, J.M., Activation of transcription factor genes in striatum by cocaine: role of both serotonin and dopamine systems, J. Pharmacol Exp. Ther., 267 (1993) 496-505.
5. 2 receptor mRNA levels in the rat striatum: effects of unilateral intrastriatal injections of 6-hydroxydopamine, Mol. Brain Res., 12 (1992) 59-67.
6. Chambers, L. and van Hartesveldt, C., Effects of intrastriatal and intracortical scopolamine on behavior in rats, Pharmacol. Biochem. Behav., 21 (1984) 471-473.
7. Chou, H., Ogawa, N., Asanuma, M., Hirata, H. and Mori, A., Muscarinic cholinergic receptor-mediated modulation on striatal c-fos mRNA expression induced by levodopa in rat brain, J. Neural Transm., 90 (1992) 171-181.
8. Consolo, S., Forloni, G., Ladinsky, H. and Palazz, E., Enhancement of opioid cataleptic response by cortical frontal deafferentation or intrastriatal injection of NMDA-receptor antagonists, Brain Res., 449 (1988) 97-103.
9. Daunais, J.B. and McGinty, J.F., Muscarinic receptors modulate apomorphine induction of dynorphin in striatal patch neurons, Soc. Neurosci. Abstr., 16 (1990) 1233.
10. Di Chiara, G., Morelli, M. and Consolo, S., Modulatory functions of neurotransmitters in the striatum: ACH/dopamine/NMDA interactions, Trends Neurosci., 17 (1994) 228-233.
11. Dickson, P.R., Lang, C.G., Hinton, S.C. and Kelley, A.E., Oral stereotypy induced by amphetamine microinjection into striatum: an anatomical mapping study, Neuroscience, 61 (1994) 81-91.
12. Dokas, L.A. and Ting, S.M., A comparison of the regulatory properties of striatal and cortical adenylate cyclase, Neurobiol. Aging, 14 (1993) 65-72.
13. Elde, R., Schalling, M., Ceddatelli, S., Nakanishi, S. and Hokeflt, T., Localization of neuropeptide receptor mRNA in rat brain: initial observations using probes for neurotensin and substance P receptors, Neurosci. Lett., 120 (1990) 134-138.
14. Fisher, S.K., Figueiredo, J.C. and Bartus, R.T., Differential stimulation of inositol phospholipid turnover in brain by analogs of oxotremorine, J. Neurochem., 43 (1984) 1171-1179.
15. Gerfen, C.R., Substance P (neurokinin-1) receptor mRNA is selectively expressed in cholinergic neurons in the striatum and basal forebrain, Brain Res., 556 (1991) 165-170.
16. Graybiel, A.M., Moratalla, R. and Robertson, H.A., Amphetamine and cocaine induce drug-specific activation of the c-fos gene in strisome-matrix and limbic subdivisions of the striatum, Proc. Natl. Acad. Sci. USA, 87 (1990) 6912-6916.
17. Guo, N., Robertson, G.S. and Fibiger, H.C., Scopolamine attenuates haloperidol-induced c-fos expression in the striatum, Brain Res., 588 (1992) 164-167.
18. Hong, J.S., Yang, H.T.T., Gillin, J.C. and Costa, E., Effects of long-term administration of antipsychotic drugs on enkephalinergic neurons, Adv. Biochem. Psychopharmacol., 24 (1980) 223-232.
19. Hulme, E.C., Birdsall, N.J.M. and Buckley, N.J., Muscarinic receptor subtypes, Annu. Rev. Pharmacol. Toxicol., 30 (1990) 633-673.
20. Jolkkonen, M., Van Giersbergen, P.L.M., Hellman, U., Wernstedt, C. and Karlsson, E., A toxin from the green mamba Dendroaspis angusticeps: amino acid sequence and selectivity for muscarinic m4 receptors, FEBS Lett., 352 (1994) 91-94.
21. Keefe, K.A. and Gerfen, C.R., D1-D2 dopamine receptor synergy in striatum: effects of intrastriatal infusions of dopamine agonists and antagonists on immediate early gene expression, Neuroscience, 66 (1995) 903-913.
22. Lucas, L.R. and Harlan, R.E., Cholinergic regulation of tachykinin- and enkephalin-gene expression in the rat striatum, Mol. Brain Res., 30 (1995) 181-195.
23. Mavridis, M., Rogard, M. and Besson, M.J., Chronic blockade of muscarinic cholinergic receptors by systemic trihexyphenidyl (Artane®) administration modulates but does not mediate the dopaminergic regulation of striatal prepropeptide messenger RNA expression, Neuroscience, 66 (1995) 37-53.
24. McGeorge, A.J. and Faull, R.L.M., The organization of the projection from the cerebral cortex to the striatum in the rat, Neuroscience, 29 (1989) 503-537.
25. Moratalla, R., Robertson, H.A. and Graybiel, A.M., Dynamic regulation of NGF1-A (zif/268, egr1) gene expression in the striatum, J. Neurosci., 12 (1992) 2609-2622.
26. 2 mediated responses, Neuroscience, 53 (1993) 673-678.
27. Morelli, M., Pinna, A., Fenu, S., Carta, A., Cozzolino, A. and Di Chiara, G., Differential effect of MK 801 and scopolamine on c-fos expression induced by L-dopa in the striatum of 6-hydroxydopamine lesioned rats, Synapse, 18 (1994) 288-293.
28. 2 receptor alterations on the contralateral side, Exp. Neurol., 121 (1993) 40-47.
29. Nisenbaum, L.K., Kitai, S.T. and Gerfen, C.R., Dopaminergic and muscarinic regulation of striatal enkephalin and substace P messenger RNAs following striatal dopamine denervation: effects of systemic and central administration of quinpirole and scopolamine, Neuroscience, 63 (1994) 435-449.
30. 2 dopaminergic regulation of striatal preproenkephalin mRNA levels in mediated at least in part through cholinergic interneurons, Mol. Brain Res., 13 (1992) 35-41.
31. Potter, L.T., Hanchett-Valentine, H., Liang, J.S., Max, S.I., Purkerson, S.L., Silberberg, H.A. and Strauss, W.L., m1-toxin, Life Sci., 52 (1993) 433-440.
32. Savaki, H.E., Raos, V.C. and Dermon, C.R., Bilateral cerebral metabolic effects of pharmacological manipulations of the substantia nigra in the rat: unilateral intranigral application of the inhibitory GABAA receptor against muscimol, Neuroscience, 50 (1992) 781-794.
33. Smith, A.J.W. and McGinty, J.F., Acute amphetamine or methamphetamine alters opioid peptide mRNA expression in rat striatum, Mol. Brain Res., 21 (1994) 359-362.
34. Steiner, H. and Gerfen, C.R., Dynorphin opioid inhibition of cocaine-induced, D1 dopamine receptor-mediated immediate-early gene expression in the striatum, J. Comp. Neurol., 353 (1995) 200-212.
35. Wang, J.Q. and McGinty, J.F., Dose-dependent alteration in zif/268 and preprodynorphin mRNA expression induced by amphetamine or methamphetamine in rat forebrain, J. Pharmacol. Exp. Ther., 273 (1995) 909-917.
36. Wang, J.Q. and McGinty, J.F., Glutamatergic and cholinergic regulation of immediate early gene and neuropeptide gene expression in the striatum. In K.M. Merchant (Ed)., Pharmacological Regulation of Gene Expression in the CNS, CRC Press, Boca Raton, 1996, pp. 81-113.
37. 2 receptor regulation of preproenkephalin and preprodynorphin mRNA in rat striatum following acute injection of amphetamine or methamphetamine, Synapse, 22 (1996) 114-122.
38. Wang, J.Q. and McGinty, J.F., Muscarinic receptors regulates striatal neuropeptide gene expression in normal and amphetamine-treated rats, Neuroscience, 75 (1996) 43-56.
39. 1 dopamine receptor agonist SKF-82958 in the intact rat striatum, Neuroscience, 72 (1996) 601-616.
40. 2 interactions by muscarinic receptors, submitted (1996).
41. Wang, J.Q., Smith, A.J.W. and McGinty, J.F., A single injection of amphetamine or methamphetamine induces dynamic alterations in c-fos, zif/268 and preprodynorphin mRNA expression in rat forebrain, Neuroscience, 68 (1995) 83-95.
42. 4 muscarinic toxin MT3 augments neuropeptide mRNA in rat striatum in vivo, NeuroReport, (1996) submitted.
43. Weiner, D.M., Levey, A. and Brann, M.R., Expression of muscarinic acetylcholine and dopamine receptor mRNAs in rat basal ganglia, Proc. Natl. Acad. Sci. USA, 87 (1990) 7050-7054.